Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes

被引:176
作者
Hotary, KB
Yana, I
Sabeh, F
Li, XY
Holmbeck, K
Birkedal-Hansen, H
Allen, ED
Hiraoka, N
Weiss, SJ
机构
[1] Univ Michigan, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA
[2] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA
关键词
matrix metalloproteinases; MT-MMP; fibrin; proteolysis; invasion;
D O I
10.1084/jem.20010815
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cross-linked fibrin is deposited in tissues surrounding wounds, inflammatory sites, or tumors and serves not only as a supporting substratum for trafficking cells, but also as a structural barrier to invasion. While the plasminogen activator-plasminogen axis provides cells with a powerful fibrinolytic system, plasminogen-deleted animals use alternate proteolytic processes that allow fibrin invasion to proceed normally. Using fibroblasts recovered from wild-type or gene-deleted mice, invasion of three-dimensional fibrin gels proceeded in a matrix metalloproteinase (MMP)-dependent fashion. Consistent with earlier studies supporting a singular role for the membrane-anchored MMP, MT1-MMP, in fibrin-invasive events, fibroblasts from MT1-MMP-null mice displayed an early defect in invasion. However, MT1-MMP-deleted fibroblasts circumvented this early deficiency and exhibited compensatory fibrin-invasive activity. The MT1-MMP-independent process was sensitive to MMP inhibitors that target membrane-anchored MMPs, and further studies identified MT2-MMP and MT3-MMP, but not MT4-MMP, as alternate pro-invasive factors. Given the widespread distribution of MT1-, 2-, and 3-MMP in normal and neoplastic cells, these data identify a subset of membrane-anchored MMPs that operate in an autonomous fashion to drive fibrin-invasive activity.
引用
收藏
页码:295 / 308
页数:14
相关论文
共 71 条
  • [1] The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin:: Implications for antiangiogenic strategies
    Bajou, K
    Masson, V
    Gerard, RD
    Schmitt, PM
    Albert, V
    Praus, M
    Lund, LR
    Frandsen, TL
    Brunner, N
    Dano, K
    Fusenig, NE
    Weidle, U
    Carmeliet, G
    Loskutoff, D
    Collen, D
    Carmeliet, P
    Foidart, JM
    Noël, AS
    [J]. JOURNAL OF CELL BIOLOGY, 2001, 152 (04) : 777 - 784
  • [2] Behrendtsen O, 1997, DEV DYNAM, V208, P255
  • [3] Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion
    Belkin, AM
    Akimov, SS
    Zaritskaya, LS
    Ratnikov, BI
    Deryugina, EI
    Strongin, AY
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) : 18415 - 18422
  • [4] Characterization of stromelysin 1 (MMP-3), matrilysin (MMP-7), and membrane type 1 matrix metalloproteinase (MT1-MMP) derived fibrin(ogen) fragments D-dimer and D-like monomer:: NH2-terminal sequences of late-stage digest fragments
    Bini, A
    Wu, D
    Schnuer, J
    Kudryk, BJ
    [J]. BIOCHEMISTRY, 1999, 38 (42) : 13928 - 13936
  • [5] Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): Hydrolysis of the gamma Gly 404-Ala 405 peptide bond
    Bini, A
    Itoh, Y
    Kudryk, BJ
    Nagase, H
    [J]. BIOCHEMISTRY, 1996, 35 (40) : 13056 - 13063
  • [6] EVOLUTION OF BODY-SIZE - CONSEQUENCES OF AN ENERGETIC DEFINITION OF FITNESS
    BROWN, JH
    MARQUET, PA
    TAPER, ML
    [J]. AMERICAN NATURALIST, 1993, 142 (04) : 573 - 584
  • [7] Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator
    Bugge, TH
    Flick, MJ
    Danton, MJS
    Daugherty, CC
    Romer, J
    Dano, K
    Carmeliet, P
    Collen, D
    Degen, JL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) : 5899 - 5904
  • [8] Bugge TH, 1997, BLOOD, V90, P4522
  • [9] CARR ME, 1987, J LAB CLIN MED, V110, P747
  • [10] EFFECT OF FIBRIN STRUCTURE ON PLASMIN-MEDIATED DISSOLUTION OF PLASMA CLOTS
    CARR, ME
    ALVING, BM
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1995, 6 (06) : 567 - 573